Tryptamine Therapeutics Ltd: Appendix 4E Preliminary Final Report

Aug 29 19:29 ET · Announcements

Tryptamine Therapeutics Completes Dosing Study for Psychotherapy Medication; Shares Up 10%

MT NewswiresAug 26 00:05 ET

Tryptamine Therapeutics Strengthens Scientific Advisory Board With Eating Disorder Expert

Investing.com Jul 29 20:00 ET

Tryptamine Therapeutics Doses First Patient in Irritable Bowel Syndrome Study

MT NewswiresJul 25 01:41 ET

Tryptamine Therapeutics Doses First Patient in IBS Clinical Study at Massachusetts General Hospital

Investing.com Jul 23 19:40 ET

Tryptamine Therapeutics Concludes Phase 2a Clinical Study for Pain and Tenderness Drug; Shares Rise 11%

MT NewswiresJul 9 23:24 ET